M

Active Director Director DIN 07565011
DIN 07565011 First appointment Aug 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2016
Shareholding value •••• Premium profile

About Mithilesh

Data last updated:

Mithilesh is a Director at Creata Pharmaceuticals (I) Private Limited (since 2016). The company operates in Pharma. Creata Pharmaceuticals (I) Private Limited reported revenue of ₹18.1 Lakh (FY 2024).

DIN 07565011
Primary Designation Director
Industry Pharma
First Appointment 04 Aug 2016
Oldest Company Age 10 yrs
Largest company Creata Pharmaceuticals (I) Private Limited · ₹18.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Aug 20162016₹18.1 Lakh (FY 2024)Active

Board colleagues of Mithilesh

NameDINCompanyDesignation
Brijesh Kumar Shukla07565055Creata Pharmaceuticals (I) Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Creata Pharmaceuticals (I) Private Limited
Premium access

Shareholding and investment profile for Mithilesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mithilesh

Mithilesh currently holds 1 directorship: Creata Pharmaceuticals (I) Private Limited (Director, since 04 Aug 2016, revenue ₹18.1 Lakh (FY 2024)).

Mithilesh was first appointed on 04 Aug 2016 as Director at Creata Pharmaceuticals (I) Private Limited.

The current boards of Mithilesh's companies include Brijesh Kumar Shukla (Creata Pharmaceuticals (I) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available